Cargando…
Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362853/ https://www.ncbi.nlm.nih.gov/pubmed/10496365 http://dx.doi.org/10.1038/sj.bjc.6690700 |
_version_ | 1782153557507571712 |
---|---|
author | Cooper, R A West, C M L Wilks, D P Logue, J P Davidson, S E Roberts, S A Hunter, R D |
author_facet | Cooper, R A West, C M L Wilks, D P Logue, J P Davidson, S E Roberts, S A Hunter, R D |
author_sort | Cooper, R A |
collection | PubMed |
description | The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74 patients with locally advanced carcinoma of the cervix. Formalin-fixed, paraffin-embedded tumour biopsies were stained with anti-factor VIII using immunohistochemistry. Vascularity was scored using the intra-tumour microvessel density (IMD), or ‘hot-spot’, technique. For the same patients, the measurement of intrinsic radiosensitivity (SF2) had been made previously on the same pretherapy samples. Patients were stratified by the median IMD and SF2 scores. Women with radioresistant and highly vascular tumours had poorer 5-year survival (P = 0.0005, P = 0.035 respectively) and local control (P = 0.012, P = 0.077 respectively) than those with radiosensitive and poorly vascular tumours. No significant correlation was seen between IMD and SF2. Multivariate analysis (including tumour stage and patient age) showed that only SF2 and IMD were significant prognostic factors for survival. Patients with both a radioresistant and highly vascular tumour had a 5-year survival level of 18% compared to 77% for those patients with a radiosensitive and poorly vascularized tumour. Tumour angiogenesis and cellular radiosensitivity are independent prognostic factors for cervix carcinoma treated with radiotherapy. Allowing for tumour radiosensitivity increases the prognostic significance of vascularity measurements in cervix tumours. © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2362853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23628532009-09-10 Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity Cooper, R A West, C M L Wilks, D P Logue, J P Davidson, S E Roberts, S A Hunter, R D Br J Cancer Regular Article The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74 patients with locally advanced carcinoma of the cervix. Formalin-fixed, paraffin-embedded tumour biopsies were stained with anti-factor VIII using immunohistochemistry. Vascularity was scored using the intra-tumour microvessel density (IMD), or ‘hot-spot’, technique. For the same patients, the measurement of intrinsic radiosensitivity (SF2) had been made previously on the same pretherapy samples. Patients were stratified by the median IMD and SF2 scores. Women with radioresistant and highly vascular tumours had poorer 5-year survival (P = 0.0005, P = 0.035 respectively) and local control (P = 0.012, P = 0.077 respectively) than those with radiosensitive and poorly vascular tumours. No significant correlation was seen between IMD and SF2. Multivariate analysis (including tumour stage and patient age) showed that only SF2 and IMD were significant prognostic factors for survival. Patients with both a radioresistant and highly vascular tumour had a 5-year survival level of 18% compared to 77% for those patients with a radiosensitive and poorly vascularized tumour. Tumour angiogenesis and cellular radiosensitivity are independent prognostic factors for cervix carcinoma treated with radiotherapy. Allowing for tumour radiosensitivity increases the prognostic significance of vascularity measurements in cervix tumours. © 1999 Cancer Research Campaign Nature Publishing Group 1999-09 /pmc/articles/PMC2362853/ /pubmed/10496365 http://dx.doi.org/10.1038/sj.bjc.6690700 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Cooper, R A West, C M L Wilks, D P Logue, J P Davidson, S E Roberts, S A Hunter, R D Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
title | Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
title_full | Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
title_fullStr | Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
title_full_unstemmed | Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
title_short | Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
title_sort | tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362853/ https://www.ncbi.nlm.nih.gov/pubmed/10496365 http://dx.doi.org/10.1038/sj.bjc.6690700 |
work_keys_str_mv | AT cooperra tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity AT westcml tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity AT wilksdp tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity AT loguejp tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity AT davidsonse tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity AT robertssa tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity AT hunterrd tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity |